Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular CarcinomaMasahito Nakano, Hiroaki Nagamatsu, Kenji Sakata et al.|Oncology|2012Cited by 34